Clinical trial
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
NCT00002475 · St. Vincent Medical Center - Los Angeles, Other · Completed
Key facts
| NCT number | NCT00002475 |
|---|---|
| Title | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer |
| Official title | A Trial of Active Intralymphatic Immunotherapy With Interferon-Treated Cells and Cyclophosphamide |
| Lead sponsor | St. Vincent Medical Center - Los Angeles, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Colorectal Cancer, Kidney Cancer, Lung Cancer, Malignant Mesothelioma, Pancreatic Cancer |
| Intervention type | Biological, Drug |
| Interventions | allogeneic tumor cell vaccine, autologous tumor cell vaccine, recombinant interferon alfa, recombinant interferon gamma, sargramostim, cyclophosphamide |
| Enrollment | 40 |
| Start date | Apr 1, 1991 |
| Primary completion | Dec 1, 2007 |
| Completion | Jun 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: